148 related articles for article (PubMed ID: 29453511)
21. The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study.
Palsdottir T; Nordstrom T; Karlsson A; Grönberg H; Clements M; Eklund M
BMJ Open; 2019 Mar; 9(3):e027958. PubMed ID: 30928965
[TBL] [Abstract][Full Text] [Related]
22. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
23. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?
Gerstenbluth RE; Seftel AD; Hampel N; Oefelein MG; Resnick MI
J Urol; 2002 Nov; 168(5):1990-3. PubMed ID: 12394692
[TBL] [Abstract][Full Text] [Related]
24. Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.
Umbehr MH; Platz EA; Peskoe SB; Bhavsar NA; Epstein JI; Landis P; Partin AW; Carter HB
BJU Int; 2014 Apr; 113(4):561-7. PubMed ID: 23746233
[TBL] [Abstract][Full Text] [Related]
25. Age-specific reference ranges for serum prostate-specific antigen in black men.
Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
[TBL] [Abstract][Full Text] [Related]
26. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.
Chiu PK; Ng CF; Semjonow A; Zhu Y; Vincendeau S; Houlgatte A; Lazzeri M; Guazzoni G; Stephan C; Haese A; Bruijne I; Teoh JY; Leung CH; Casale P; Chiang CH; Tan LG; Chiong E; Huang CY; Wu HC; Nieboer D; Ye DW; Bangma CH; Roobol MJ
Eur Urol; 2019 Apr; 75(4):558-561. PubMed ID: 30396635
[TBL] [Abstract][Full Text] [Related]
27. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
28. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.
Shao YH; Albertsen PC; Roberts CB; Lin Y; Mehta AR; Stein MN; DiPaola RS; Lu-Yao GL
Arch Intern Med; 2010 Jul; 170(14):1256-61. PubMed ID: 20660846
[TBL] [Abstract][Full Text] [Related]
29. Are age-specific reference ranges for prostate specific antigen population specific?
Wolff JM; Brehmer B; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):4981-3. PubMed ID: 11326652
[TBL] [Abstract][Full Text] [Related]
30. General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.
Wong LM; Johnston R; Sharma N; Shah NC; Warren AY; Neal DE
BJU Int; 2012 Jul; 110(1):24-7. PubMed ID: 22077729
[TBL] [Abstract][Full Text] [Related]
31. A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies.
Boesen L; Thomsen FB; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thomsen HS; Jakobsen H
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):609-616. PubMed ID: 30988407
[TBL] [Abstract][Full Text] [Related]
32. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
[TBL] [Abstract][Full Text] [Related]
33. An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study.
Eldred-Evans D; Tam H; Sokhi H; Padhani AR; Connor M; Price D; Gammon M; Klimowska-Nassar N; Burak P; Day E; Winkler M; Fiorentino F; Ahmed HU
Eur Urol Oncol; 2023 Jun; 6(3):295-302. PubMed ID: 37080821
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of high-grade or insignificant prostate cancer in Korean men with prostate-specific antigen levels of 3.0-4.0 ng/mL.
Choi SK; Song C; Shim M; Min GE; Park J; Jeong IG; Hong JH; Kim CS; Ahn H
Urology; 2015 Mar; 85(3):610-5. PubMed ID: 25586476
[TBL] [Abstract][Full Text] [Related]
35. Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Yang DD; Mahal BA; Muralidhar V; Vastola ME; Boldbaatar N; Labe SA; Nezolosky MD; Orio PF; King MT; Martin NE; Mouw KW; Trinh QD; Nguyen PL
Clin Genitourin Cancer; 2018 Jun; 16(3):226-234. PubMed ID: 29196209
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
Pinsky PF; Andriole G; Crawford ED; Chia D; Kramer BS; Grubb R; Greenlee R; Gohagan JK
Cancer; 2007 Apr; 109(8):1689-95. PubMed ID: 17330856
[TBL] [Abstract][Full Text] [Related]
37. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.
Roddam AW; Hamdy FC; Allen NE; Price CP;
BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men.
Shim HB; Lee SE; Park HK; Ku JH
Yonsei Med J; 2007 Aug; 48(4):678-83. PubMed ID: 17722242
[TBL] [Abstract][Full Text] [Related]
40. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
